2. Nicoli F., Clave E., Wanke K., von Braun A., Bondet V., Alanio C. et al. Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old. EBioMedicine 2022; 76: 103852. DOI: 10.1016/j.ebiom.2022.103852.

3. Мелехина Е.В., Музыка А.Д., Калугина М.Ю., Горелов А.В., Чугунова О.Л. Современные представления об инфекции, вызванной вирусом герпеса человека 6-го типа. Архивъ внутренней медицины 2016; 27(1): 13–9. DOI: 10.20514/2226-6704-2016-6-1-13-19

Melehina E.V., Muzyka A.D., Kalugina M.Ju., Gorelov A.V., Chugunova O.L. [Current cjncept of human herpesvirus type 6 infection]. Arkhiv vnutrenney meditsiny 2016; 27(1): 13–9. (In Russ.). DOI: 10.20514/2226-6704-2016-6-1-13-19

4. Гузов С.А., Недзьведь М.К Патологическая анатомия герпетической инфекции: диагностика, формы, место в диагнозе. Минск: БГМУ, 2015. 20 c. Доступно по: https://docviewer.yandex.ru/view/95235475

Guzov S.A., Nedzved M.K. [Patologicheskaia anatomiia gerpeticheskoi infekcii: diagnostika, formi, mesto v diagnose]. Minsk: BGMU, 2015. 20 p. (In Russ.). https://docviewer.yandex.ru/view/95235475

5. Герпетическая инфекция у взрослых. Клинические протоколы МЗ Республики Казахстан 2015. 35 с. https://diseases.medelement.com/disease/14166

[Herpetic infection in adults. Clinical protocols of the Ministry of Health of the Republic of Kazakhstan]. 2015. 35 р. (In Russ.). https://diseases. medelement.com/disease/14166

6. Литусов Н.В. Герпесвирусы. Екатеринбург: УГМУ, 2018. 26 c. https://text.ru/rd/aHR0cHM6Ly9kb2NwbGF5ZXIuY29tLzM2Mzk

Litusov N.V. [Herpesvirusy]. Ekaterinburg: UGMU, 2018. 26 p. (In Russ). https://text.ru/rd/aHR0cHM6Ly9kb2NwbGF5ZXIuY29tLzM2Mzk

7. Franceschini E., Cozzi-Lepri A., Santoro A., Bacca E., Lancellotti G., Menozzi M. et al. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study. Microorganisms 2021; 9(9): 1896. DOI: 10.3390/microorganisms9091896.

8. Deana C., Vetrugno L., Stefani F., Bassi F. Bronchoscopic suspect of Herpesvirus infection in critically ill COVID-19 patients: two case reports and brief literature review. Acta Biomed [Internet]. 2022; 92(S1): e2021514. https://www. mattioli1885journals.com/index.php/actabiomedica/article/view/1242

9. Xu R., Zhou Y., Cai L., Wang L., Han J., Yang X. et al. Co-reactivation of the human herpesvirus alpha subfamily (Herpes Simplex virus-1 and Varicella Zoster virus) in a critically ill patient with COVID-19. Br. J. Dermatol. 2020; 183(6): 1145–7. DOI: 10.1111/bjd.19484

10. Busani S., Bedini A., Biagioni E., Serio L., Tonelli R., Meschiari M. et al.; Modena Covid-19 Working Group (MoCo19). Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies. Clin. Infect. Dis. 2021; 73(1): e252–5. DOI: 10.1093/cid/ciaa1246.

11. Shanshal M., Ahmed H.S. COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study. Cureus 2021; 13(9): e18022. DOI: 10.7759/cureus

12. Соломай Т.В., Семененко Т.А., Исаева Е.И., Ветрова Е.Н., Чернышова А.И., Роменская Э.В., Каражас Н.В. COVID- 19 и риск реактивации герпесвирусной инфекции. Эпидемиол. инфекц. болезни. Актуал. вопр. 2021; 11(2): 55–62.

Solomay T.V., Semenenko T.A., Isaeva E.I., Vetrova E.N., Chernyshova A.I., Romenskaya E.V., Karazhas N.V. [COVID-19 and the risk of herpesvirus reactivation]. Epidemiology and infectious diseases. Сurrent items 2021; 11(2): 55–62. (In Russ.). DOI: 10.18565/epidem.2021.11.2.55–62

13. Галинова И.В. Факторы риска преждевременных родов. Все ли однозначно? Наука молодых (Eruditio Juvenium) 2021; 9(1): 77–90.

Galinova I.V. [Risk factors for premature birth. Is everything unambiguous?] Science of the young (Eruditio Juvenium) 2021; 9(1): 77–90. (In Russ.). DOI: 10.23888/HMJ20219177-90

14. Diez-Domingo J., Parikh R., Bhavsar A.B., Cisneros E., McCormick N., Lecrenier N. Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review. Dermatol Ther (Heidelb.). 2021; 11(4): 1119–26. DOI: 10.1007/s13555-021-00549-1.

15. Adam I. Is herpes zoster being an indicator for COVID-19 infection? Dermato.l Ther. 2020; 33(5): e13846. DOI: 10.1111/dth.13846.

16. Elsaie M.L., Youssef E.A., Nada H.A. Herpes Zoster might be an indicator for latent COVID-19 infection. Dermatol. Ther. 2020; 33(4): e13666. DOI: 10.1111/dth.13666.

17. Pona A., Jiwani R.A., Afriyie F., Labbe J., Cook P.P., Mao Y. Herpes Zoster as a potential complication of coronavirus disease 2019. Dermatol. Ther. 2020; 33(6): e13930. DOI: 10.1111/dth.13930. Epub 2020 Jul 13. PMID: 32602610; PMCID: PMC7361152

18. Cao X., Zhang X., Meng W., Zheng H. Herpes Zoster and Postherpetic Neuralgia in an Elderly Patient with Critical COVID-19: A Case Report. J. Pain .Res. 2020; 13: 2361– 5. DOI: 10.2147/JPR.S274199. PMID: 33061551; PMCID: PMC7519825

19. Algaadi S.A. Herpes Zoster and COVID-19 infection: a coincidence or a causal relationship? Infection 2021; 22: 1–5. DOI: 10.1007/s15010-021-01714-6. Epub ahead of print. PMID: 34807403; PMCID: PMC8607065

20. Alfishawy M., Nassar M., Assal H.H., Ibrahim A.K., Abdalla M.S., Nso N., Elbendary A. Human Herpesviruses Reactivation in COVID-19. Ann. Pulm. Res. Med. 2021; 1(1): 1004. DOI: https://www.researchgate.net/publication/351716559_Human_Herpesviruses_Reactivation_in_COVID-19?enrichId=rgreq-59990ff0eafa1275a4457a3e2fbd9821-XXX&enrichSource= Y292ZXJQYWdlOzM1MTcxNjU1OTtBUzoxMDI1NTE4NTU2MTc2Mzg3QDE2MjE1MTQwODU5MDE%3D&el=1_x_2&_esc=publicationCoverPdf

21. Katz J., Yue S., Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Irish. J. Med. Sci. 2021; 20(3): e573–82. DOI: 10.1007/s11845-021-02714-z

22. Maldonado M.D., Romero-Aibar J., Pérez-San-Gregorio M.A. COVID-19 pandemic as a risk factor for the reactivation of herpes viruses. Epidemiol. Infect. 2021; 149: e145. DOI: 10.1017/S0950268821001333.

23. Le Balc’h P., Pinceaux K., Pronier C., Seguin P., Tadié J.-M., Reizine F. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit. Care. 2020; 24(1): 530. DOI: 10.1186/s13054-020-03252-3

24. Coisel Y., Bousbia S., Forel J.-M., Hraiech S., Lascola B., Roch A. et al. Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One 2012; 7(12). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517464/

25. Al-Omari A., Aljamaan F., Alhazzani W., Salih S., Arabi Y. Cytomegalovirus infection in immunocompetent critically ill adults: literature review. Ann. Intensive Care 2016; (6). https://www.ncbi.nlm. nih.gov/pmc/articles/PMC5095093/.

26. Lino K., Alves L.S., Raposo J.V. et al. Presence and clinical impact of human herpesvirus‐6 infection in patients with moderate to critical coronavirus disease‐19. J. Med. Virol. 2022; 94 (3): 1212–6. DOI: 10.1002/jmv.27392

27. Drago F., Ciccarese G., Rebora A., Parodi A. Human herpesvirus-6, -7, and Epstein–Barr virus reactivation in pityriasisrosea during COVID-19. J. Med. Virol. 2021; 93(4): 1850–1. DOI: 10.1002/jmv.26549

28. Korge B. Pityriasis rosea. Reaktivierung einer humanen Herpesvirus-6- und -7-Infektion? Hautarzt. 2003; 54(1): 78–9. DOI: 10.1007/s00105-002-0474-1

29. Paolucci S., Cassaniti I., Novazzi F., Fiorina L., Piralla A., Comolli G. et al. San Matteo Pavia COVID-19 Task Force. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int. J. Infect. Dis. 2021; 104: 315–9. DOI: 10.1016/j.ijid.2020.12.051

30. García-Martínez F.J., Moreno-Artero E., Jahnke S. SARS-CoV-2 and EBV coinfection. Med. Clin. (Barc). 2020; 155(7): 319–20. DOI: 10.1016/j.medcli.2020.06.017

31. Gardini G., Odolini S., Moioli G., Papalia D.A., Ferrari V., Matteelli A., Caligaris S. Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature. Eur. J. Med. Res. 2021; 26(1): 152. DOI: 10.1186/s40001-021-00620-9

32. Proal A.D., van Elzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021; 12: 698169. DOI: 10.3389/fmicb.2021.698169

33. Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021; 10(6): 763. DOI: 10.3390/pathogens10060763

34. Добин В.Л., Горбунов А.В., Муратов Е.Н. Клиническое наблюдение необычного течения коронавирусной инфекции у больного с хроническим диссеминированным туберкулезом легких и ВИЧ. Российский медико-биологический вестник имени академика И.П. Павлова 2021; 29(4): 539–43.

Dobin V.L., Gorbunov A.V., Muratov E.N. [Clinical case of an unusual course of coronavirus infection in patient with chronic disseminated pulmonary tuberculosis and human immunodeficiency virus infection]. I.P. Pavlov Russian Medical Biological Herald 2021; 29(4): 539–43. (In Russ.). DOI: https://doi.org/10.17816/PAVLOVJ65124